A study to compare the efficacy,safety and Quality of life in patients with Moderate Diabetic Peripheral Neuropathic Pain on Pregabalin versus Amitriptyline at a tertiary care centre-A Randomised Control Study

Chronic pain in patients with diabetic peripheral neuropathy significantly affects physical functioning emotional well-being and overall quality of life Pregabalin and Amitriptyline are commonly used first-line agents for pain management This study could  highlight evident variations in their impact on quality of life with Pregabalin and Amitriptyline conferring more substantial improvements in overall QoL particularly across the domains of energy sleep and emotional well-being